Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/1/1994
1.
Phase I Study of Fostriecin in Patients with Advanced Solid Tumors (Summary Last Modified 09/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
UCCRC-6159
NCI-T91-0106C, T91-0106
Last Modified:
6/28/2004
2.
Phase I Study of Fostriecin in Patients with Advanced Cancer (Summary Last Modified 03/96)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
CAN-NCIC-IND67
NCI-T91-0196O, T91-0196, IND67
Last Modified:
5/1/1995
3.
Phase I Study of Fostriecin in Patients with Advanced Solid Tumors (Summary Last Modified 05/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
16 and over
NCI
MDA-DM-92001
NCI-T92-0006D, T92-0006
Last Modified:
6/1/1994
4.
Phase I Study of Fostriecin in Patients with Advanced Solid Tumors (Summary Last Modified 06/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 to 75
NCI
DUT-T92-0066
NCI-T92-0066A, T92-0066
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute